Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease
pharmaceutical investing Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan
U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease
Silverco Mining Announces Filing of Q2 2026 Financial Statements and MD&A and Provides Corporate Update
Silver Hammer and Stroud Resources Announce up to C$10 Million Brokered Financing in Connection with Silver Frontier Transaction
Heritage Confirms High-Grade Gold Mineralization at The Melba Project Returning 15.57g/t Au over 9m from 43m, Including: 28.98g/t Au over 4.80m
